Exploring the Modulation of Plasma p-tau181 Protein in Alzheimers Disease: A Clinical Trial with Saraswata Ghrita Nasya(nasal instillation) Interventio
Phase 3
- Conditions
- Health Condition 1: G308- Other Alzheimers disease
- Registration Number
- CTRI/2024/03/063642
- Lead Sponsor
- Director of All India Institute of Ayurveda
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.Patients between the age group of 50 to 80 years.
2.Patients of both genders.
3.Diagnosed case Diagnosed case of AD as per DSM IV criteria
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1 Effect on clinical signs and symptoms and ADAS scale for Alzheimer’s disease patients and effect on improving quality of life of Alzheimer’s disease patients would be determined. <br/ ><br>2 Modulatory effect of Saraswata Ghrita on the plasma expression of protein Plasma phosphorylated tau181 (p-tau181) protein of Alzheimer’s Disease patients would be evaluated. <br/ ><br> <br/ ><br>Timepoint: <br/ ><br>assessment will be at base line ie zero day and at 90th day
- Secondary Outcome Measures
Name Time Method ILTimepoint: NI